Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 4:05 pm Purchase | 13G | CITY OFFICE REIT INC CIO | Newtyn Management LLC | 3,938,000 9.800% | 734,758 (+22.94%) | View |
2024-11-14 4:05 pm Unchanged | 13G | Tectonic Therapeutic Inc. TECX | Newtyn Management LLC | 0 0.000% | 0 (Unchanged) | View |
2024-11-14 4:05 pm Purchase | 13G | FRANKLIN STREET PROPERTIES CORP FSP | Newtyn Management LLC | 7,150,000 6.900% | 7,150,000 (New Position) | View |
2024-11-14 4:05 pm Sale | 13G | BV FINL INC BVFL | Newtyn Management LLC | 682,980 5.800% | -317,020 (-31.70%) | View |
2024-08-16 4:05 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Newtyn Management LLC | 4,100,000 8.400% | 4,100,000 (New Position) | View |
2024-03-08 4:05 pm Purchase | 13G | VERADIGM INC. MDRX | Newtyn Management LLC | 10,500,000 9.600% | 10,500,000 (New Position) | View |
2024-03-07 6:00 pm Sale | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management LLC | 1,242,245 4.950% | -214,428 (-14.72%) | View |
2024-02-14 4:05 pm Purchase | 13G | Tectonic Therapeutic Inc. TECX | Newtyn Management LLC | 2,734,175 6.100% | 2,734,175 (New Position) | View |
2024-02-14 4:05 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | Newtyn Management LLC | 3,021,500 8.400% | 3,021,500 (New Position) | View |
2024-02-14 4:05 pm Purchase | 13G | CITY OFFICE REIT INC CIO | Newtyn Management LLC | 3,203,242 8.000% | 3,203,242 (New Position) | View |
2024-02-14 4:05 pm Purchase | 13G | BV FINL INC BVFL | Newtyn Management LLC | 1,000,000 8.800% | 1,000,000 (New Position) | View |
2024-02-14 4:05 pm Sale | 13G | PG&E CORP EQUITY UNIT PCGU | Newtyn Management LLC | 0 0.000% | -665,610 (Position Closed) | View |
2024-02-13 5:34 pm Sale | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management LLC | 1,456,673 5.830% | -277,485 (-16.00%) | View |
2024-01-25 4:05 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Newtyn Management LLC | 1,873,694 13.100% | 354,587 (+23.34%) | View |
2023-11-03 5:03 pm Purchase | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management LLC | 1,734,158 6.500% | 1,734,158 (New Position) | View |
2023-05-23 4:05 pm Sale | 13G | PG&E CORP EQUITY UNIT PCGU | Newtyn Management LLC | 665,610 6.500% | -583,164 (-46.70%) | View |
2023-02-14 4:06 pm Purchase | 13G | PFSWEB INC PFSW | Newtyn Management LLC | 1,206,502 5.300% | 1,206,502 (New Position) | View |
2023-02-14 4:05 pm Sale | 13G | PG&E CORP EQUITY UNIT PCGU | Newtyn Management LLC | 1,248,774 12.100% | -38,767 (-3.01%) | View |
2022-03-04 6:02 pm Purchase | 13G | PG&E CORP EQUITY UNIT PCGU | Newtyn Management LLC | 1,287,541 12.500% | 529,608 (+69.88%) | View |
2022-03-04 6:00 pm Purchase | 13G | PG&E CORP EQUITY UNIT PCGU | Newtyn Management LLC | 757,933 7.300% | 757,933 (New Position) | View |